221 related articles for article (PubMed ID: 21494531)
1. Left main stent thrombosis complicated by eptifibatide-induced acute thrombocytopenia.
Yang EH; Perez E; Zhiroff KA; Burstein S
Tex Heart Inst J; 2011; 38(2):174-8. PubMed ID: 21494531
[TBL] [Abstract][Full Text] [Related]
2. Eptifibatide-induced thrombocytopenia: with thrombosis and disseminated intravascular coagulation immediately after left main coronary artery percutaneous coronary angioplasty.
Tempelhof MW; Benzuly KH; Fintel D; Krichavsky MZ
Tex Heart Inst J; 2012; 39(1):86-91. PubMed ID: 22412237
[TBL] [Abstract][Full Text] [Related]
3. Acute profound thrombocytopenia associated with readministration of eptifibatide: case report and review of the literature.
Russell KN; Schnabel JG; Rochetto RP; Tanner MC
Pharmacotherapy; 2009 Jul; 29(7):867-74. PubMed ID: 19558261
[TBL] [Abstract][Full Text] [Related]
4. Primary percutaneous coronary angioplasty with and without eptifibatide in ST-segment elevation myocardial infarction: a safety and efficacy study of integrilin-facilitated versus primary percutaneous coronary intervention in ST-segment elevation myocardial infarction (ASSIST).
Le May MR; Wells GA; Glover CA; So DY; Froeschl M; Marquis JF; O'Brien ER; Turek M; Thomas A; Kass M; Jadhav S; Labinaz M
Circ Cardiovasc Interv; 2009 Aug; 2(4):330-8. PubMed ID: 20031736
[TBL] [Abstract][Full Text] [Related]
5. Drug-eluting stent thrombosis 1,659 days after stent deployment: case report and literature review.
Al-Dehneh A; Virk H; Alkhouri Y; Hamdan A; Bikkina M
Tex Heart Inst J; 2010; 37(3):343-6. PubMed ID: 20548819
[TBL] [Abstract][Full Text] [Related]
6. Bridging with glycoprotein IIb/IIIa inhibitors for periprocedural management of antiplatelet therapy in patients with drug eluting stents.
Ben Morrison T; Horst BM; Brown MJ; Bell MR; Daniels PR
Catheter Cardiovasc Interv; 2012 Mar; 79(4):575-82. PubMed ID: 22448399
[TBL] [Abstract][Full Text] [Related]
7. Eptifibatide-induced thrombocytopenia.
Refaat M; Smith AJ; Edmundowicz D
J Thromb Thrombolysis; 2008 Apr; 25(2):204-6. PubMed ID: 18008040
[TBL] [Abstract][Full Text] [Related]
8. The effects of aspirin and clopidogrel response on myonecrosis after percutaneous coronary intervention: a BRIEF-PCI (Brief Infusion of Intravenous Eptifibatide Following Successful Percutaneous Coronary Intervention) trial substudy.
Saw J; Densem C; Walsh S; Jokhi P; Starovoytov A; Fox R; Wong G; Buller C; Ricci D; Mancini GB; Fung A
JACC Cardiovasc Interv; 2008 Dec; 1(6):654-9. PubMed ID: 19463380
[TBL] [Abstract][Full Text] [Related]
9. Upstream clopidogrel use and the efficacy and safety of early eptifibatide treatment in patients with acute coronary syndrome: an analysis from the Early Glycoprotein IIb/IIIa Inhibition in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome (EARLY ACS) trial.
Wang TY; White JA; Tricoci P; Giugliano RP; Zeymer U; Harrington RA; Montalescot G; James SK; Van de Werf F; Armstrong PW; Braunwald E; Califf RM; Newby LK
Circulation; 2011 Feb; 123(7):722-30. PubMed ID: 21300952
[TBL] [Abstract][Full Text] [Related]
10. Eptifibatide-induced thrombocytopenia leading to acute stent thrombosis.
Dézsi DA; Bokori G; Faluközy J; Bujáky C; Fogarassy G; Veress G; Aradi D
J Thromb Thrombolysis; 2016 Apr; 41(3):522-4. PubMed ID: 26305043
[TBL] [Abstract][Full Text] [Related]
11. Severe thrombocytopenia possibly related to readministration of eptifibatide.
Paradiso-Hardy FL; Madan M; Radhakrishnan S; Hurden S; Cohen EA
Catheter Cardiovasc Interv; 2001 Sep; 54(1):63-7. PubMed ID: 11553950
[TBL] [Abstract][Full Text] [Related]
12. Reversible thrombocytopenia associated with eptifibatide.
Yoder M; Edwards RF
Ann Pharmacother; 2002 Apr; 36(4):628-30. PubMed ID: 11918511
[TBL] [Abstract][Full Text] [Related]
13. Eptifibatide-Induced Profound Thrombocytopenia After Percutaneous Intervention for Acute Coronary Syndrome: A Challenging Clinical Scenario.
Bhatia N; Sawyer RD; Ikram S
Methodist Debakey Cardiovasc J; 2017; 13(4):248-252. PubMed ID: 29744018
[TBL] [Abstract][Full Text] [Related]
14. Late stent thrombosis associated with heavy exercise.
Simsek Z; Arslan S; Gundogdu F
Tex Heart Inst J; 2009; 36(2):154-7. PubMed ID: 19436813
[TBL] [Abstract][Full Text] [Related]
15. Clopidogrel loading with eptifibatide to arrest the reactivity of platelets: results of the Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets (CLEAR PLATELETS) study.
Gurbel PA; Bliden KP; Zaman KA; Yoho JA; Hayes KM; Tantry US
Circulation; 2005 Mar; 111(9):1153-9. PubMed ID: 15738352
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous subacute thrombosis of bare metal coronary stents in two different arteries early after clopidogrel cessation.
Canpolat U; Yorgun H; Atalar E
Cardiol J; 2012; 19(3):309-13. PubMed ID: 22641551
[TBL] [Abstract][Full Text] [Related]
17. Comparison of two platelet glycoprotein IIb/IIIa inhibitors, eptifibatide and abciximab: outcomes, complications and thrombocytopenia during percutaneous coronary intervention.
Suleiman M; Gruberg L; Hammerman H; Aronson D; Halabi M; Goldberg A; Grenadier E; Boulus M; Markiewicz W; Beyar R
J Invasive Cardiol; 2003 Jun; 15(6):319-23. PubMed ID: 12777670
[TBL] [Abstract][Full Text] [Related]
18. Stent parameters predict major adverse clinical events and the response to platelet glycoprotein IIb/IIIa blockade: findings of the ESPRIT trial.
Tcheng JE; Lim IH; Srinivasan S; Jozic J; Gibson CM; O'Shea JC; Puma JA; Simon DI
Circ Cardiovasc Interv; 2009 Feb; 2(1):43-51. PubMed ID: 20031692
[TBL] [Abstract][Full Text] [Related]
19. Prolonged infusion of eptifibatide as bridge therapy between bare-metal stent insertion and cardiovascular surgery: case report and review of the literature.
Pickett AM; Taylor DA; Ackman ML
Pharmacotherapy; 2010 Apr; 30(4):127e-33e. PubMed ID: 20334463
[TBL] [Abstract][Full Text] [Related]
20. Elective percutaneous coronary intervention using broad-spectrum antiplatelet therapy (eptifibatide, clopidogrel, and aspirin) alone, without scheduled unfractionated heparin or other antithrombin therapy.
Denardo SJ; Davis KE; Tcheng JE
Am Heart J; 2005 Jan; 149(1):138-44. PubMed ID: 15660045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
